Podcasts – Contract Pharma
5 days ago · Pharma Matters Contract Pharma Talks with Jim Donovan of Pfizer CentreOne. Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.
Latest magazine issues – Contract Pharma
Stay informed with the latest financial reports and updates in the pharma industry. View all
Contract Pharma – Contract Pharma is the premier media outlet …
Contract Pharma Contract Pharma Talks with Jim Donovan of Pfizer CentreOne. Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.
Library – Contract Pharma
News Releases Former Assets of a cGMP Contract Research Organization – Multi Location Auction. Federal Equipment Company and Proxio Group are collaborating to auction off the former assets of a cGMP Contract Research Organization.
Digital Technology – Contract Pharma
LGM Pharma’s chief executive talks industry trends and the company’s continued growth as a provider of tailored API and CDMO services. Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors ...
subscription – Contract Pharma
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.
Breaking News – Contract Pharma
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry. View all
Videos – Contract Pharma
VideoBites Contract Pharma Talks with Tom Handel of Kindeva Drug Delivery. Commercial Head of Injectables and Health Security for Kindeva Drug Delivery talks about the Bridgeton, Missouri aseptic injectable fill-finish facility.
CPhI North America – Contract Pharma
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.
Samsung Invests in Generate: Biomedicines – Contract Pharma
Dec 18, 2024 · The Samsung Life Science Fund has invested in Generate: Biomedicines as part of its efforts to drive growth and innovation in the biopharmaceutical sector. Established in 2021 and worth KRW 240 billion, the fund also invested in BrickBio earlier this year. Generate, founded by Flagship Pioneering, is a US-based clinical-stage company leading in generative biology.